Sign In
Buy IDXG
$1.75
-0.0100 (-0.568%)
At Close: Jun 03, 2026
Annovis Bio (ANVS) Initiated with a Buy at Maxim Group - Markets
11:16am, Friday, 19'th Jun 2020
Maxim Group analyst Jason McCarthy initiated coverage with a Buy rating on Annovis Bio (ANVS – Research Report) today and
HTG Molecular Diagnostics (HTGM) Gets a Buy Rating from H.C. Wainwright - Markets
10:18am, Friday, 19'th Jun 2020
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on HTG Molecular Diagnostics (HTGM –
Interpace Diagnostics Group (NASDAQ:IDXG) Stock Rating Upgraded by ValuEngine
01:48am, Friday, 19'th Jun 2020
Interpace Diagnostics Group (NASDAQ:IDXG) was upgraded by research analysts at ValuEngine from a “buy” rating to a “strong-buy” rating in a research report issued on Wednesday, ValuEngine repo
BioNano Genomics (BNGO) Receives a Buy from Oppenheimer - Markets
01:33am, Friday, 19'th Jun 2020
In a report released yesterday, Kevin DeGeeter from Oppenheimer maintained a Buy rating on BioNano Genomics (BNGO – Research Report),
The
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Armata Pharmaceuticals
Zacks: Brokerages Anticipate Interpace Diagnostics Group Inc (NASDAQ:IDXG) Will Announce Earnings of -$1.19 Per Share
03:16am, Thursday, 18'th Jun 2020
Equities analysts expect Interpace Diagnostics Group Inc (NASDAQ:IDXG) to announce earnings of ($1.19) per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have ma
Navidea (NAVB) Gets a Buy Rating from Maxim Group - Markets
03:51pm, Tuesday, 16'th Jun 2020
Maxim Group analyst Jason McCarthy assigned a Buy rating to Navidea (NAVB – Research Report) today and set a price
Analysts Are Bullish on These Healthcare Stocks: Momenta Pharma (MNTA), Otonomy (OTIC) - Markets
10:08am, Tuesday, 16'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Momenta Pharma
Global Molecular Diagnostics Partnering Terms and Agreements 2014 - 2020 - ResearchAndMarkets.com
12:00am, Tuesday, 16'th Jun 2020
The
Avita Medical (RCEL) Gets a Buy Rating from Oppenheimer - Markets
02:10pm, Monday, 15'th Jun 2020
Oppenheimer analyst Kevin DeGeeter assigned a Buy rating to Avita Medical (RCEL – Research Report) today and set a price
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Global Blood Therapeutics (GBT –
Global Molecular Diagnostics Market - Technologies, Products, Applications and End-Use Sectors to 2022 - ResearchAndMarkets.com
12:00am, Monday, 15'th Jun 2020
The
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CytoDyn (CYDY
The
